Erectile Dysfunction Management for the Future

被引：12
作者：
Burnett, Arthur L. [1 ]
机构：
[1] Johns Hopkins Univ Hosp, Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD 21287 USA
来源：
JOURNAL OF ANDROLOGY | 2009年 / 30卷 / 04期
关键词：
Pharmacotherapy; growth factor therapy; gene therapy; regenerative medicine; penis; erection; CAVERNOSUM SMOOTH-MUSCLE; PENILE ERECTION; GUANYLATE-CYCLASE; CHANNEL OPENERS; RAT PENIS; THERAPY; TISSUE; GENE; INHIBITION; RELAXATION;
D O I：
10.2164/jandrol.108.006106
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
The field of erectile dysfunction (ED) management over time has witnessed assorted interventions to enable men to perform sexual intercourse. In recent times, major progress in ED research has led to increasingly effective treatments based on a refined knowledge of the scientific basis for penile erection. Current concepts suggest that therapeutic prospects on the horizon include novel pharmacotherapies, growth factor therapy, gene therapy, and regenerative medicine. The purpose of this review is to present the foundations for future therapies in ED management.
引用
收藏
页码：391 / 396
页数：6
相关论文
共 27 条
[1]  
Andersson KE, 2001, PHARMACOL REV, V53, P417
[2]   Central control of penile erection: Role of the paraventricular nucleus of the hypothalamus [J].
Argiolas, A ;
Melis, MR .
PROGRESS IN NEUROBIOLOGY, 2005, 76 (01) :1-21
[3]   Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence [J].
Becker, AJ ;
Ückert, S ;
Stief, CG ;
Truss, MC ;
Machtens, S ;
Scheller, F ;
Knapp, WH ;
Hartmann, U ;
Jonas, U .
UROLOGY, 2001, 57 (01) :193-198
[4]   Emerging neuromodulatory molecules for the treatment of neurogenic erectile dysfunction caused by cavernous nerve injury [J].
Bella, Anthony J. ;
Lin, Guiting ;
Cagiannos, Ilias ;
Lue, Tom F. .
ASIAN JOURNAL OF ANDROLOGY, 2008, 10 (01) :54-59
[5]   Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction [J].
Brioni, JD ;
Nakane, M ;
Hsieh, GC ;
Moreland, RB ;
Kolasa, T ;
Sullivan, JP .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2002, 14 (01) :8-14
[6]   Application of angiogenic factors for therapy of erectile dysfunction: protein and DNA transfer of VEGF 165 into the rat penis [J].
Burchardt, M ;
Burchardt, T ;
Anastasiadis, AG ;
Buttyan, R ;
de la Taille, A ;
Shabsigh, A ;
Frank, J ;
Shabsigh, R .
UROLOGY, 2005, 66 (03) :665-670
[7]   Neuromodulatory therapy to improve erectile function recovery outcomes after pelvic surgery [J].
Burnett, Arthur L. ;
Lue, Tom F. .
JOURNAL OF UROLOGY, 2006, 176 (03) :882-887
[8]   Nitric oxide/redox-based signalling as a therapeutic target for penile disorders [J].
Burnett, Arthur L. ;
Musicki, Biljana ;
Jin, Liming ;
Bivalacqua, Trinity J. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (03) :445-457
[9]   Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunction [J].
Cawello, W ;
Schweer, H ;
Dietrich, B ;
Seyberth, HW ;
Albrecht, D ;
Fox, A ;
Hohmuth, H .
JOURNAL OF UROLOGY, 1997, 158 (04) :1403-1407
[10]  
Christ G J, 1993, Int J Impot Res, V5, P77
123